Navigation Links
BIO 2009 -- R&D session: New stem cell research unlocks unknown therapies
Date:5/15/2009

Meet Dr Jonas Frisen, one of the most successful scientists within stem cell research, at an R&D session in the worlds largest convention for biotech and pharmaceuticals, BIO 2009 in Atlanta, USA. The session is arranged by the Swedish medical university Karolinska Institutet, SwedenBIO and Invest in Sweden Agency.

Dr. Frisn will talk about stem cell research, currently one of the most exciting areas in science, and how it unravels potential new therapies for Parkinson's, Alzheimer's, spinal cord injury, stroke, heart diseases and other devastating diseases.

He is also the scientific founder of NeuroNova, a biopharmaceutical company, developing stem cell-based therapies for neurological disorders in the central nervous system. NeuroNova has two drug candidates in clinical development, one for Parkinson's disease and one for ALS.

The session will be chaired by Ceci Connolly, National Healthcare Reporter at Washington Post.

R&D session at BIO 2009 - Breaking new stem cell research unlocks unknown therapies
Time: Thursday 21 May at 10:00 am.
Location: Georgia World Congress Center, Room B308, Atlanta.

Key Speaker: Jonas frisn, M.D., Ph.D., Tobias Foundation Professor of Stem Cell Research, Karolinska Institutet, Sweden.
Speaker: Lilian Wikstrm, Ph.D., Head of Research, NeuroNova AB.
Chair: Ceci Connolly, National Healthcare Reporter, Washington Post.


'/>"/>

Contact: Sabina Bossi
sabina.bossi@ki.se
46-706-146-066
Karolinska Institutet
Source:Eurekalert

Page: 1

Related biology news :

1. New partnership offers outsourced R&D in membrane biology
2. Oak Ridge to lead auto supplier R&D partnership
3. Singapore opens Fusionopolis, its second major R&D hub in 5 years
4. NTU seals global partnerships on environmental sciences R&D
5. Research shows skeleton to be endocrine organ
6. Newly created cancer stem cells could aid breast cancer research
7. Dominant cholesterol-metabolism ideas challenged by new research
8. Researchers identify proteins involved in new neurodegenerative syndrome
9. Texas researchers and educators head for Antarctica
10. MGH researchers describe new way to identify, evolve novel enzymes
11. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global ... reach $11.4 billion by 2021, growing at a compound annual ... - An overview of the global markets for synthetic biology. ... estimates for 2016, and projections of compound annual growth rates ...
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... February 24, 2017 , ... FireflySci, Inc is an explosive small business that ... the goal of bringing their powerful cuvette and spectrophotometer calibration to the ... FireflySci is going on as they add yet another mark on the global map. ...
(Date:2/24/2017)... Corporation (NASDAQ: VWR), the leading global independent provider of product ... its financial results for the fourth quarter and full year ... 4Q16 record quarterly net sales of $1.13 billion, up ... 4Q16 EMEA-APAC segment net sales increased ... net sales increased 2.5%, or down 0.9% on an organic ...
(Date:2/23/2017)... NEW YORK , Feb. 23, 2017 ... a leading digital health company, and Digital ... telemedicine and remote patient monitoring, announce they are ... DN Telehealth maximizes collaboration compatibility ... extending consultations beyond a physical clinical setting to ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook Labs is formalizing ... an array of biochemical analyses critical for Lead Discovery. The company’s Lead ... SAR programs, including inhibitor potency and selectivity, mechanism of action, and inhibitor residence ...
Breaking Biology Technology: